Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Radiology and Neuroradiology, Klinikum Dortmund, Dortmund, Germany.
Clin Neuroradiol. 2019 Jun;29(2):311-319. doi: 10.1007/s00062-017-0657-x. Epub 2018 Jan 10.
The application of radiopaque markers to the Solitaire™ stent-retriever for better visibility during mechanical thrombectomy (MT) has the potential to alter the well-known characteristics of the device; however, it is uncertain whether this adjustment influences efficacy or safety of the enhanced stent-retriever.
Retrospective analysis of stroke databases of three comprehensive stroke centers. Our investigation was focused on technical and angiographic parameters, including procedure times, reperfusion results (thrombolysis in cerebral infarction, TICI), periprocedural complications and favorable early neurological recovery at discharge (modified Rankin scale ≤2 or National Institutes of Health Stroke Scale, NIHSS = 0 or ∆NIHSS ≥ 10), from consecutive patients with acute anterior circulation ischemic stroke treated with a Solitaire™ Platinum stent-retriever between October 2016 and March 2017.
A total of 75 patients (male: n = 27, 36%, age in years: mean (SD): 75 (±12), median baseline NIHSS: 17 (interquartile range IQR: 11-21), n = 41, 54.7% received additional i. v. thrombolytics) were treated with a median number of 2 device passes (range: 1-5). The median time from groin puncture to final TICI was 56 min (IQR: 41-79). In 69 patients (92%) TICI 2b-3 was achieved. Early neurological recovery was seen in 47 (62.7%) patients. The following periprocedural complications occurred: vasospasms (n = 7, 9.3%), emboli into a new territory (n = 4, 5.3%), symptomatic intracranial hemorrhage (n = 3, 4%), difficulties during device delivery/deployment (n = 1, 1.3%).
The usage of the Solitaire™ Platinum stent-retriever for MT in acute ischemic stroke patients was highly effective and was not accompanied by an increased periprocedural complication rate.
在机械取栓术(MT)中应用不透射线标志物来提高 Solitaire™ 支架取栓器的可视性,可能会改变该器械众所周知的特性;然而,目前尚不确定这种调整是否会影响增强型支架取栓器的疗效和安全性。
对三个综合卒中中心的卒中数据库进行回顾性分析。我们的研究重点是技术和血管造影参数,包括手术时间、再灌注结果(脑梗死溶栓,TICI)、围手术期并发症以及出院时的早期神经功能恢复(改良 Rankin 量表≤2 或国立卫生研究院卒中量表,NIHSS=0 或△NIHSS≥10),连续 75 例接受 Solitaire™ Platinum 支架取栓器治疗的急性前循环缺血性卒中患者。
75 例患者(男性:n=27,36%,年龄:平均(标准差):75(±12)岁,中位数基线 NIHSS:17(四分位距 IQR:11-21),n=41,54.7%接受了额外的静脉溶栓治疗),使用支架取栓器的中位数次数为 2 次(范围:1-5)。从腹股沟穿刺到最终 TICI 的中位数时间为 56 分钟(IQR:41-79)。69 例(92%)患者达到 TICI 2b-3。47 例(62.7%)患者早期神经功能恢复。发生以下围手术期并发症:血管痉挛(n=7,9.3%)、新部位栓塞(n=4,5.3%)、症状性颅内出血(n=3,4%)、器械输送/部署困难(n=1,1.3%)。
在急性缺血性卒中患者中使用 Solitaire™ Platinum 支架取栓器进行 MT 是非常有效的,且不会增加围手术期并发症的发生率。